News
BEAT
0.3885
-1.57%
-0.0062
Analysts Offer Insights on Healthcare Companies: HealthStream (HSTM), Neurocrine (NBIX) and HeartBeam (BEAT)
TipRanks · 2d ago
Press Release: HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time
Dow Jones · 3d ago
HeartBeam's 3D ECG Shows Promising Results In Heart Attack Assessment Pilot Study
NASDAQ · 3d ago
HeartBeam announces results from ALIGN-ACS pilot study of HeartBeam System
TipRanks · 4d ago
Weekly Report: what happened at BEAT last week (1026-1030)?
Weekly Report · 4d ago
HeartBeam Announces Positive Heart Attack Pilot Study Results at TCT 2026: Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG
Barchart · 4d ago
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
Barchart · 10/28 07:31
HeartBeam announces U.S. FDA accepted HeartBeat System to its TAP Pilot
TipRanks · 10/26 12:41
HeartBeam Wins FDA Total Product Life Cycle Advisory Program Pilot Acceptance For Heart Attack Assessment Technology
Benzinga · 10/26 12:35
Weekly Report: what happened at BEAT last week (1019-1023)?
Weekly Report · 10/26 10:01
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
Barchart · 10/26 07:31
HeartBeam announces HEADSTART-ACS study completed enrollment
TipRanks · 10/21 12:40
HeartBeam Completes Enrollment Ahead Of Schedule In 486-Patient HEADSTART-ACS Study
Benzinga · 10/21 12:40
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
Barchart · 10/21 07:31
Weekly Report: what happened at BEAT last week (1012-1016)?
Weekly Report · 10/19 10:01
HeartBeam Joins Philips-Led EXIT-CVD Consortium For Cardiovascular Research In Europe; Stock Up
NASDAQ · 10/15 13:48
HeartBeam joins European EXIT-CVD Research Consortium
TipRanks · 10/15 12:40
HeartBeam Named Contributing Partner In Launch Of EXIT-CVD Research Project, Co-Funded By European Union Innovative Health Initiative And Industry Partners
Benzinga · 10/15 12:37
Weekly Report: what happened at BEAT last week (1005-1009)?
Weekly Report · 10/12 10:06
Why These 3 Penny Stocks Are on Investors’ Radar Today
TipRanks · 10/06 14:16
More
Webull provides a variety of real-time BEAT stock news. You can receive the latest news about Heartbeam Inc through multiple platforms. This information may help you make smarter investment decisions.
About BEAT
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.